Retrospective Comparison of SADI-S Versus RYGB in Chinese with Diabetes and BMI< 35kg/m2: a Propensity Score Adjustment Analysis.
Qing SangLiang WangQiqige WuyunXuejing ZhengDezhong WangNengwei ZhangDexiao DuPublished in: Obesity surgery (2021)
In Chinese with diabetes and BMI< 35 kg/m2, with comparable T2DM remission and nutritional outcomes, primary SADI-S allows for better weight loss than RYGB. Compared with RYGB, SADI-S is also a safe, effective, and feasible treatment for these patients.
Keyphrases
- roux en y gastric bypass
- weight loss
- glycemic control
- type diabetes
- cardiovascular disease
- body mass index
- end stage renal disease
- gastric bypass
- newly diagnosed
- ejection fraction
- bariatric surgery
- weight gain
- peritoneal dialysis
- obese patients
- cross sectional
- systemic lupus erythematosus
- patient reported outcomes
- adipose tissue
- skeletal muscle
- physical activity
- ulcerative colitis
- disease activity
- patient reported
- combination therapy
- replacement therapy
- smoking cessation